MA48455A - Composés anticancéreux - Google Patents

Composés anticancéreux

Info

Publication number
MA48455A
MA48455A MA048455A MA48455A MA48455A MA 48455 A MA48455 A MA 48455A MA 048455 A MA048455 A MA 048455A MA 48455 A MA48455 A MA 48455A MA 48455 A MA48455 A MA 48455A
Authority
MA
Morocco
Prior art keywords
cancer compounds
cancer
compounds
Prior art date
Application number
MA048455A
Other languages
English (en)
Other versions
MA48455B1 (fr
Inventor
Marchante Maria Del Carmen Cuevas
Solloso Andres Francesch
Barrasa Valentin Martinez
Original Assignee
Pharma Mar Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma Mar Sa filed Critical Pharma Mar Sa
Priority claimed from PCT/EP2018/060868 external-priority patent/WO2018197663A1/fr
Publication of MA48455A publication Critical patent/MA48455A/fr
Publication of MA48455B1 publication Critical patent/MA48455B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D515/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D515/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4995—Pyrazines or piperazines forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MA48455A 2017-04-27 2018-04-27 Composés antitumoraux MA48455B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17382228 2017-04-27
PCT/EP2018/060868 WO2018197663A1 (fr) 2017-04-27 2018-04-27 Composés anticancéreux

Publications (2)

Publication Number Publication Date
MA48455A true MA48455A (fr) 2020-03-04
MA48455B1 MA48455B1 (fr) 2023-06-28

Family

ID=58668823

Family Applications (3)

Application Number Title Priority Date Filing Date
MA48455A MA48455B1 (fr) 2017-04-27 2018-04-27 Composés antitumoraux
MA57420A MA57420B1 (fr) 2017-04-27 2018-04-27 Composés anticancéreux
MA58643A MA58643B1 (fr) 2017-04-27 2018-04-27 Composés anticancéreux

Family Applications After (2)

Application Number Title Priority Date Filing Date
MA57420A MA57420B1 (fr) 2017-04-27 2018-04-27 Composés anticancéreux
MA58643A MA58643B1 (fr) 2017-04-27 2018-04-27 Composés anticancéreux

Country Status (2)

Country Link
AR (1) AR114387A1 (fr)
MA (3) MA48455B1 (fr)

Also Published As

Publication number Publication date
AR114387A1 (es) 2020-09-02
MA58643B1 (fr) 2023-09-27
MA57420B1 (fr) 2023-06-28
MA48455B1 (fr) 2023-06-28

Similar Documents

Publication Publication Date Title
EP3720430A4 (fr) Composés benzocarbonyle
EP3691623A4 (fr) Composés de benzosulfonyle
MA47131A (fr) Composés benzyl-amide phosphodiamide antiviraux
MA49701A (fr) Composés immunomodulateurs
EP3532069A4 (fr) Composés aryl-amide phosphodiamide antiviraux
EP3474845A4 (fr) Composés immunomodulateurs
MA44020A (fr) Composés antitumoraux
MA44233A (fr) Nouveaux composés
MA41614A (fr) Composés antiviraux
MA44050A (fr) Nouveaux composés
MA42293A (fr) Composés antibactériens
ME03419B (fr) Composés dihydroisoquinolinone substitués
EP3445750A4 (fr) Composés thérapeutiques
EP3609871A4 (fr) Composés d'amide aryl cyclopropyl-amino-isoquinolinyl
EP3464336A4 (fr) Composés
DK3612519T3 (da) Phenyl-2-hydroxy-acetylamino-2-methyl-phenyl forbindelser
EP3728289A4 (fr) Composés optimisés
MA49621A (fr) Composés bifonctionnels
EP3310352A4 (fr) Composés cristallins
EP3717483A4 (fr) Composés de pyrazolopyridinone
EP3713941A4 (fr) Composés de pyrazolopyridinone
MA49522A (fr) Nouveaux composés de quinoléinone
EP3259254A4 (fr) Composés thérapeutiques
MA49885A (fr) Composés macrocycliques
EP3504269A4 (fr) Composés de fluoroélastomère